The drug, molnupiravir, could be authorized within days for patients at high risk of severe illness.
Published: November 30, 2021 at 11:10AM
from NYT Health https://ift.tt/3E5iiI1
The drug, molnupiravir, could be authorized within days for patients at high risk of severe illness.
Published: November 30, 2021 at 11:10AM
from NYT Health https://ift.tt/3E5iiI1